Cargando…
Rapid onset of efficacy predicts response to therapy with certolizumab plus methotrexate in patients with active rheumatoid arthritis
BACKGROUND/AIMS: The objective of this study was to determine the efficacy and safety of add-on therapy with certolizumab pegol (CZP) in active rheumatoid arthritis (RA) patients of a single ethnicity. METHODS: In this 24-week, phase 3, randomized, double-blind, placebo-controlled trial, eligible pa...
Autores principales: | Kang, Young Mo, Park, Young-Eun, Park, Won, Choe, Jung-Yoon, Cho, Chul-Soo, Shim, Seung-Cheol, Bae, Sang Cheol, Suh, Chang-Hee, Cha, Hoon-Suk, Koh, Eun Mi, Song, Yeong-Wook, Yoo, Bin, Lee, Shin-Seok, Park, Min-Chan, Lee, Sang-Heon, Arendt, Catherine, Koetse, Willem, Lee, Soo-Kon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association of Internal Medicine
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6234400/ https://www.ncbi.nlm.nih.gov/pubmed/29294598 http://dx.doi.org/10.3904/kjim.2016.213 |
Ejemplares similares
-
Erratum to “Low Baseline Interleukin-17A Levels Are Associated with Better Treatment Response at 12 Weeks to Tocilizumab Therapy in Rheumatoid Arthritis Patients”
por: Lee, Sang Jin, et al.
Publicado: (2017) -
Low Baseline Interleukin-17A Levels Are Associated with Better Treatment Response at 12 Weeks to Tocilizumab Therapy in Rheumatoid Arthritis Patients
por: Lee, Sang Jin, et al.
Publicado: (2015) -
Two Dosing Regimens of Certolizumab Pegol in Patients With Active Rheumatoid Arthritis
por: Furst, D E, et al.
Publicado: (2015) -
Treat-to-Target Strategy for Asian Patients with Early Rheumatoid Arthritis: Result of a Multicenter Trial in Korea
por: Song, Jason Jungsik, et al.
Publicado: (2018) -
Efficacy and safety of tocilizumab in Korean patients with active rheumatoid arthritis
por: Baek, Han Joo, et al.
Publicado: (2019)